Stay updated on SCT: Lisdexamfetamine Trial for ADHD & SCT
Sign up to get notified when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.

Latest updates to the SCT: Lisdexamfetamine Trial for ADHD & SCT page
- Check4 days agoChange DetectedLocations now lists New York under the Locations section, replacing the previous 'New York Locations' entry. This clarifies the site of the study for potential participants and researchers.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a note that PubMed publications are auto-filled and may not be about the study, and updated the page revision to v3.3.2. The previous wording describing PubMed publications as automatically created by ClinicalTrials.gov with revision v3.2.0 was removed.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding status notice was removed from the page. The study details, eligibility criteria, and listed outcomes remain unchanged.SummaryDifference0.4%

- Check54 days agoChange DetectedThe updates appear to be minor visual/layout changes to the Study Details page with no modifications to core trial content such as eligibility criteria, interventions, or primary outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check90 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the previous version tag v3.0.2 as background.SummaryDifference0.5%

Stay in the know with updates to SCT: Lisdexamfetamine Trial for ADHD & SCT
Enter your email address, and we'll notify you when there's something new on the SCT: Lisdexamfetamine Trial for ADHD & SCT page.